Miguel Ángel Reyes
Director
Alivia
/
View from the Top

Alivia: Low-Cost, High-Quality Treatments for Insurers

By Antonio Gozain | Thu, 03/17/2022 - 13:29

Q: How has Alivia’s footprint grown over the past two years?

A: Alivia’s growth has been exponential and focused on the market’s needs. Over the past two years, we opened seven new clinics in five cities, for a total of 14 clinics. Our goal is to satisfy insurers’ needs based on the potential for cost reduction.

Q: How important for Alivia is to have a patient-centric approach?

A: Alivia walks patients through the entire process, helping them at various points, such as getting medicines, managing their insurance and keeping track of the treatment. We remind patients when to return for their next appointment to continue the treatment in the most efficient way possible.

Q: What does the 360-degree business model mean?

A: Alivia’s business model involves several players, including healthcare professionals, insurers, drug manufacturers and distributors. We are involved in the entire chain to guarantee the best care for insured patients.

Q: How does the company reduce costs for insurers?

A: We work to get the best prices from drug manufacturers and distributors, reducing costs for insurers by 30 percent when compared with hospitals. In addition, insurers benefit from our work with patients to get them to complete their treatments. If patients do not finish their treatments, the disease will worsen and represent higher expenses for the insurer.

Q: What are the benefits of Alivia’s infusion centers?

A: Alivia works with doctors to avoid the unnecessary hospitalization of patients, reducing costs. Infusion therapies have evolved to become less invasive, allowing patients to avoid hospitalization by visiting these infusion centers. Alivia covers several specialties in all of our clinics.

Q: How does Alivia address the home care trend?

A: Home care must be monitored by a doctor and nurse. Not all therapies can be carried out at home but this model can be used for non-invasive procedures. We offer this benefit for certain patients with mobility complications, as long as their doctor approves it.

Q: How does Alivia’s relationship with healthcare professionals work?

A: Our executives visit healthcare professionals to offer our service and business model. As we continue our work, more doctors will become acquainted with Alivia’s benefits and first-class service. We also maintain constant communication with patients’ doctors.

Q: How have medicine shortages impacted Alivia?

A: Public institutions were badly hit by medicine shortages. Some of Alivia’s patients are on social security or have a major medical expenses policy and did not want to wait to continue their therapies in the public sector. Between 15-20 percent of patients come from public institutions,  preferring to continue their therapies with us.

Q: How does Alivia leverage technology for drug distribution?

A: Alivia has direct contact with both drug manufacturers and distributors to learn about new therapies or drugs. Our system enables us to plan the distribution of drugs in the cities where we operate depending on when they will be needed. These technological tools help us to correctly manage medicines and always have them when they are required.

Q: What are Alivia’s top priorities for 2022?

A: Alivia will continue looking for new areas of opportunity to help insurers reduce costs. We communicate continuously with insurers to understand where our services are needed. Alivia is constantly analyzing this information to continue expanding and reaching more patients.

 

Alivia is the largest independent provider of specialty pharmacy and infusion services in the country. It works with the entire healthcare ecosystem to provide medications and information to those suffering from chronic and rare diseases.

Photo by:   Alivia
Antonio Gozain Antonio Gozain Journalist and Industry Analyst